Gene Techno Science Co., Ltd.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gene Techno Science Co., Ltd..The latest application filed is for "method for diagnosing, preventing and treating cancer brain metastasis, and drug delivery system for enabling passage through blood-brain barrier".

Company Profile

4.13.9

Gene Techno Science Co., Ltd. - Sapporo-shi JP
GENE TECHNO SCIENCE CO., LTD. - Sapporo-shi, Hokkaido N/A JP
Gene Techno Science Co., Ltd. - Hokkaido JP
GENE TECHNO SCIENCE CO., LTD. -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Suppressing Brain Metastasis App 20200216912A1 -	2020-07-09
Method for diagnosing and treating cancer brain metastasis and drug delivery system for enabling passage through blood-brain barrier Grant 10,544,466 - Ochiya , et al. Ja	2020-01-28
Method For Diagnosing, Preventing And Treating Cancer Brain Metastasis, And Drug Delivery System For Enabling Passage Through Blood-brain Barrier App 20180274035 - Ochiya; Takahiro ; et al.	2018-09-27
Anti-human .alpha.9 integrin antibody and use thereof Grant 9,040,295 - Kon , et al. May 26, 2	2015-05-26
Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same Grant 8,901,280 - Kon , et al. December 2, 2	2014-12-02
Humanized anti-.alpha. 9 integrin antibodies and the uses thereof Grant 8,821,863 - Kumar , et al. September 2, 2	2014-09-02
Generation, expression and characterization of the humanized K33N monoclonal antibody Grant 8,735,552 - Kumar , et al. May 27, 2	2014-05-27
Soluble Integrin Alpha-4 Mutant App 20140135483 - Seito; Tsutomu ; et al.	2014-05-15
Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof Grant 8,617,829 - Kumar , et al. December 31, 2	2013-12-31
Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof Grant 8,614,296 - Kumar , et al. December 24, 2	2013-12-24
Anti-ADAM-15 antibodies and utilization of the same Grant 8,461,310 - Uede , et al. June 11, 2	2013-06-11
Anti-human Alpha9 Integrin Antibody And Use Thereof App 20130122019 - Kon; Shigeyuki ; et al.	2013-05-16
Anti-human .alpha.9 integrin antibody and use thereof Grant 8,372,639 - Kon , et al. February 12, 2	2013-02-12
Humanized Antibodies Specific For Amino Acid Sequence Rgd Of An Extracellular Matrix Protein And The Uses Thereof App 20120219503 - Kumar; Shankar ; et al.	2012-08-30
Antihuman .alpha.9 integrin antibody and use of the same Grant 8,221,754 - Kanayama , et al. July 17, 2	2012-07-17
Anti-human Alpha9 Integrin Antibody And Use Thereof App 20110318368 - Kon; Shigeyuki ; et al.	2011-12-29
Humanized Antibodies Specific For Amino Acid Sequence Rgd Of An Extracellular Matrix Protein And The Uses Thereof App 20110091386 - Kumar; Shankar ; et al.	2011-04-21
Antibody Against Rgd In Amino Acid Sequence Of Extracellular Matrix Protein And Production Method And Use Of The Same App 20110065899 - Kon; Shigeyuki ; et al.	2011-03-17
Anti-.alpha.9 integrin antibody and the use thereof Grant 7,595,045 - Kurotaki , et al. September 29, 2	2009-09-29
Anti-Alpha9 Integrin Antibody And The Use Thereof App 20080152653 - Kurotaki; Daisuke ; et al.	2008-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.